Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,516.3
-14.0 (-0.55%)

 

  • STI Straits Times Index
    2,516.3
    -14.0 (-0.55%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,454.2
    17.4 (1.21%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,254.5
    -130.2 (-0.56%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,842.0
    -4.5 (-0.16%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,293.7
    22.5 (0.11%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,621.5
    -5.3 (-0.11%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 409.5M
  • Value: 335.0M
  • Rise: 109
  • Fall: 88
  • Unch: 611

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Reenova Investment^0.003+0.001
Medtecs Intl0.205+0.015
UG Healthcare0.435+0.065
MarcoPolo Marine0.013+0.001
ComfortDelGro1.530-
Rex Intl0.143-0.001
Dyna-Mac0.115+0.006
Singapore-eDev0.056+0.003
Clearbridge0.196+0.012
Golden Agri-Res0.148+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,340.2 +15.6
HSI 23,258.3 -126.3
HSCEI 9,554.1 -41.1
Jakarta 4,621.7 -5.1
Nikkei 225 21,291.9 +20.7
SSE Comp 2,842.0 -4.5
Shanghai A 2,978.8 -4.7
Shanghai B 207.7 -0.4
KOSPI 2,027.9 -1.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VOYAGER THERAPEUTICS INC VOYAGER THERAPEUTICS INC
Updated on 26 May 2020 (End of trading day)
Last (USD): 12.590 Change: -0.400 High: 13.430 Remarks: -
Change (%): -3.08 Low: 12.545
Open 13.430 Yesterday's Close 12.99
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 408,991 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.17308 Trailing EPS (USD) e -1.09489 NAV (USD) b 2.1460
PE a - Trailing PE f - Price / NAV b 5.8667
Dividend (USD) d - Cash In Hand (USD) g 4.4458 Issued & Paid-up Shares c 37,164,600
Dividend Yield (%) d - Price / Cash In Hand g 2.832 Treasury Shares h -
Beta - 75 Daysi 1.193 R-Squared - 75 Days(%)i 44.19 Market Cap (M) 467.902
Beta - 500 Daysi 0.765 R-Squared - 500 Days (%)i 8.41 Enterprise Value (M) 250.365
Piotroski F Score 3 Exchange Code VYGR Par Value ( $ ) n.a.
52 Weeks Volatility (%) 74.48 Free Float (%) 64.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 24 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 09 Nov 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VOYAGER THERAPEUTICS INC NASDAQ 467.902 - - 5.8667 -
Industry Biotechnology NASDAQ 2,772.137 361.669 68678.556 6.8161 0.692
Local Peer AMGEN INC NASDAQ 130,826.133 16.683 17.046 13.7929 2.622
Local Peer GILEAD SCIENCES INC NASDAQ 91,767.720 17.038 18.494 4.1586 3.477
Local Peer VERTEX PHARMACEUTICAL NASDAQ 69,097.321 58.716 45.732 10.6934 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 61,348.103 28.995 26.915 5.0563 -
Local Peer ILLUMINA INC NASDAQ 52,098.270 51.994 55.306 11.2402 -
Local Peer BIOGEN INC NASDAQ 48,282.138 8.199 8.213 3.8481 -
Local Peer SEATTLE GENETICS INC NASDAQ 26,264.766 - - 14.8756 -
Local Peer MODERNA INC NASDAQ 21,423.337 - - 13.0560 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,701.016 9.442 9.562 1.9324 -
Local Peer INCYTE CORPORATION NASDAQ 21,450.368 47.998 - 11.0699 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 18,760.030 - 164.553 5.7902 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 15,426.413 - - 11.4293 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), UNIQURE N.V. (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), NOVAVAX INC (NASDAQ), ALECTOR INC (NASDAQ), INSMED INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), EPIZYME INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), REGENXBIO INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), VERACYTE INC (NASDAQ), MACROGENICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), COMPUGEN (NASDAQ), PASSAGE BIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), RETROPHIN INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ARDELYX INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AVROBIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), NANTKWEST INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROTHENA CORP PLC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MERUS B V (NASDAQ), PRECIGEN INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), XBIOTECH INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), PERSONALIS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PDL BIOPHARMA INC (NASDAQ), KAMADA (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CHIASMA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), VERMILLION INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), XOMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AFFIMED N V (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), VAXART INC (NASDAQ), INFLARX N V (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), IVERIC BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), ARAVIVE INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), LUMOS PHARMA INC (NASDAQ), COHBAR INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), RESTORBIO INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), SYNLOGIC INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), VACCINEX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), EQUILLIUM INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), ZAFGEN INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ATYR PHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), TOCAGEN INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CURIS INC (NASDAQ), EVOGENE LTD (NASDAQ), BIOCARDIA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PRECIPIO INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 139,679.094 52.062 48.219 16.1508 0.862
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer AGILENT TECHNOLOGIES INC NYSE 26,670.241 24.902 39.049 5.5936 0.760
Global Peer WUXI BIO HKEx 159,288.514 138.564 138.564 11.1386 -
Global Peer SINO BIOPHARM HKEx 148,281.342 48.311 48.311 4.2608 0.676
Global Peer BEIGENE HKEx 98,653.660 - - 4.5260 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,404.459 80.816 64.676 4.0979 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 31,861.485 - - 10.6821 -
Global Peer 3SBIO HKEx 22,871.885 20.715 20.715 2.1243 -
Other Global Peers ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), VIVA BIOTECH (HKEx), MESOBLAST LTD (ASX), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), LEE'S PHARM (HKEx), DPHARMA (Bursa), BBI LIFE SCI (HKEx), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), ENZO BIOCHEM INC (NYSE), IBIO INC (NYSE American), CEL-SCI CORP (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), UNI-BIO GROUP (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), IMUGENE LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), BIOTRON (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), MEMPHASYS LTD (ASX), BIOSINO BIO-TEC (HKEx), ORAGENICS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES (ASX), Suntar Eco-City^ (SGX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIONOMICS LTD (ASX), REGENT PACIFIC (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), SIENNA CANCER DIAGNOSTICS LTD (ASX), REGENEUS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), HAO WEN HLDGS (HKEx), AMPLIA THERAPEUTICS LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), LEAF RESOURCES LTD (ASX), CRYOSITE (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.320
-2.48 %
10 Days -+0.800
+6.79 %
20 Days -+0.980
+8.44 %
Medium Term Return 3 Months -+0.650
+5.44 %
6 Months --1.130
-8.24 %
1 Year --11.010
-46.65 %
Long Term Return 2 Years --7.690
-37.92 %
3 Years -+3.750
+42.42 %
Annualised Return Annualised --
+12.51 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.260 - 28.790 Change From 1 Year Low +6.330 % Change From 1 Year Low (%) +101.12
Change From 1 Year High -16.200 % Change From 1 Year High (%) -56.27
2 Years Range 6.260 - 28.790 Change From 2 Years Low +6.330 % Change From 2 Years Low (%) +101.12
Change From 2 Years High -16.200 % Change From 2 Years High (%) -56.27
5 Years Range 6.260 - 31.910 Change From 5 Years Low +6.330 % Change From 5 Years Low (%) +101.12
Change From 5 Years High -19.320 % Change From 5 Years High (%) -60.55
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guangping Gao, Mark A. Kay, Krystof Bankiewicz and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
26 May 2020 13.430 13.430 12.545 12.590 408,991 -
22 May 2020 12.970 13.120 12.580 12.990 195,993 -
21 May 2020 12.960 13.032 12.350 12.870 341,997 -
20 May 2020 13.100 13.260 12.670 12.900 265,711 -
19 May 2020 13.040 13.470 12.810 12.910 375,467 -
18 May 2020 12.570 13.140 12.320 13.010 481,210 -
15 May 2020 11.240 11.900 11.116 11.880 235,788 -
14 May 2020 11.520 11.570 10.920 11.250 273,517 -
13 May 2020 12.000 12.290 10.970 11.530 252,670 -
12 May 2020 12.600 12.940 11.770 11.790 389,120 -
11 May 2020 11.070 12.380 11.070 12.380 421,921 -
08 May 2020 11.060 11.450 10.860 11.150 316,397 -
07 May 2020 11.530 11.820 10.700 10.780 373,207 -
06 May 2020 11.500 11.770 11.200 11.360 339,608 -
05 May 2020 11.360 11.800 11.320 11.460 271,402 -
04 May 2020 10.500 11.140 10.310 11.130 331,132 -
01 May 2020 10.580 10.670 10.010 10.580 261,126 -
30 Apr 2020 11.620 11.620 10.770 10.810 284,857 -
29 Apr 2020 11.960 12.064 11.660 11.760 223,578 -
28 Apr 2020 11.800 11.885 11.440 11.610 257,538 -
27 Apr 2020 11.200 11.660 11.140 11.510 260,611 -
24 Apr 2020 10.680 11.200 10.560 11.180 257,935 -
Summary
Current 2 Weeks
(12 May 2020 to 26 May 2020)
12.600 13.470 10.920 12.590 3,220,464 -
Previous 2 Weeks
(28 Apr 2020 to 11 May 2020)
11.800 13.470 10.920 12.380 3,080,766 -
4 Weeks from
(30 Mar 2020 to 27 Apr 2020)
9.110 13.470 8.200 11.510 7,286,974 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.